| Institution: | 1. Department of Chemical Engineering and Biotechnology, University of Applied Sciences Darmstadt, Stephanstraße 7, 64295 Darmstadt, Germany;2. Department of Chemical Engineering and Biotechnology, University of Applied Sciences Darmstadt, Stephanstraße 7, 64295 Darmstadt, Germany
Institute of Functional Interfaces (IFG), Karlsruhe Institute of Technology (KIT), Hermann-von-Helmholtz Platz-1, 76334 Eggenstein-Leopoldshafen, Germany;3. Institute of Functional Interfaces (IFG), Karlsruhe Institute of Technology (KIT), Hermann-von-Helmholtz Platz-1, 76334 Eggenstein-Leopoldshafen, Germany |
| Abstract: | Human histone deacetylase 8 is a well-recognized target for T-cell lymphoma and particularly childhood neuroblastoma. PD-404,182 was shown to be a selective covalent inhibitor of HDAC8 that forms mixed disulfides with several cysteine residues and is also able to transform thiol groups to thiocyanates. Moreover, HDAC8 was shown to be regulated by a redox switch based on the reversible formation of a disulfide bond between cysteines Cys102 and Cys153. This study on the distinct effects of PD-404,182 on HDAC8 reveals that this compound induces the dose-dependent formation of intramolecular disulfide bridges. Therefore, the inhibition mechanism of HDAC8 by PD-404,182 involves both, covalent modification of thiols as well as ligand mediated disulfide formation. Moreover, this study provides a deep molecular insight into the regulation mechanism of HDAC8 involving several cysteines with graduated capability to form reversible disulfide bridges. |
